FDA 483 - Deerland Enzymes Inc. - December 23, 2014

An FDA inspection of Deerland Enzymes Inc., a dietary supplement manufacturer in Kennesaw, GA, revealed significant deficiencies in manufacturing controls and facility sanitation. Observations included the absence of master manufacturing records, inadequate sampling of components, and improper storage of hazardous materials. The inspection also noted repeat observations regarding the accumulation of litter and waste, highlighting persistent issues.